Immunic Share Price

Immunic Share Price

NASDAQ: IMUX | Small Cap | Healthcare
$7.02
-$0.44 (-5.9%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Immunic Stock Performance

Open
$7.32
Prev. Close
$7.46
Circuit Range
N/A
Day Range
$7.00 - $7.49
Year Range
$0.51 - $17.34
Volume
3,683
Average Traded
$7.15

Immunic Share Price Today

As of 22 November 2026, Immunic, Inc.'s share price is $7.02. The stock opened at $7.32, compared to its previous close of $7.46. During today's trading session, Immunic, Inc.'s share price traded between $7.00 and $7.49, with an average price of $7.24. Over the past 52 weeks, the stock has recorded a high of $17.34 and a low of $0.51. In terms of performance, Immunic, Inc.'s share price has declined by 53.14% over the last six months and is up 885.96% on a year-on-year basis.

Immunic Share Price Chart

Line chart of the Immunic price trend over the selected period. The price fell overall, ranging from 6.99 to 7.49, ending at 7.02.
$7.00$7.49
L
Show Current Price
H

Immunic Stock Fundamentals & Key Indicators

Market Cap
$1.09B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.08
Revenue (TTM)
$0.00
Return On Equity (TTM)
-122.80%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-119.22%

Immunic Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.30-$32.59-$34.10-$42.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-68.86%-4.63%-24.08%

Immunic Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$120.41-$93.61-$100.51-$97.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A22.26%-7.37%3.32%

Immunic Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.181.541.771.89
Current Assets22.8739.3352.53125.86
Total Assets24.0540.8754.3127.75
Non Current Liabilities0.110.260.640.99
Current Liabilities30.6222.1824.7313.08
Total Liabilities30.7322.4425.3714.07
Shareholders' Equity-6.6718.4328.93113.68

Immunic Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-85.81-84.77-70.83-65.14
Investing-0.16-0.269.46-9.74
Financing65.5874.541.0395.76

Corporate Actions

Split
Ex-date: 27 Apr 2026

About Immunic

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Immunic Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.62
$7.00
-6.79%
Oct 2026
$9.22
$7.51
-20.02%
Sep 2026
$16.02
$9.39
-42.39%
Aug 2026
$13.91
$16.30
+16.51%
Jul 2026
$15.12
$13.99
-9.27%
Jun 2026
$15.21
$15.42
+2.94%
May 2026
$9.65
$14.98
+56.04%
Apr 2026
$1.14
$9.60
+768.78%
Mar 2026
$0.99
$1.10
+9.41%
Feb 2026
$0.62
$1.01
+63.17%
Jan 2026
$0.55
$0.62
+16.14%
Dec 2025
$0.71
$0.53
-25.14%

Immunic Share Price FAQs